Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye.

× No keyword cloud information.

10 in total

Review 1. Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?

Authors: Heiner Wedemeyer
Journal: Nat Rev Gastroenterol Hepatol Date: 2013-01-08 Impact factor: 46.802

Review 2. [Which treatment options are validated for chronic viral hepatitis?].

Authors: C Höner zu Siederdissen; M P Manns; M Cornberg
Journal: Internist (Berl) Date: 2013-12 Impact factor: 0.743

Review 3. Simeprevir: a review of its use in patients with chronic hepatitis C virus infection.

Authors: Mark Sanford
Journal: Drugs Date: 2015-02 Impact factor: 11.431

4. Treatment Extension of Pegylated Interferon Alpha and Ribavirin Does Not Improve SVR in Patients with Genotypes 2/3 without Rapid Virological Response (OPTEX Trial): A Prospective, Randomized, Two-Arm, Multicentre Phase IV Clinical Trial.

Authors: Benjamin Heidrich; Hans-Jörg Cordes; Hartwig Klinker; Bernd Möller; Uwe Naumann; Martin Rössle; Michael R Kraus; Klaus H Böker; Christoph Roggel; Marcus Schuchmann; Albrecht Stoehr; Andreas Trein; Svenja Hardtke; Andrea Gonnermann; Armin Koch; Heiner Wedemeyer; Michael P Manns; Markus Cornberg
Journal: PLoS One Date: 2015-06-09 Impact factor: 3.240

5. PEG-IFN alpha but not ribavirin alters NK cell phenotype and function in patients with chronic hepatitis C.

Authors: Antoaneta A Markova; Ulrike Mihm; Verena Schlaphoff; Sebastian Lunemann; Natalie Filmann; Birgit Bremer; Thomas Berg; Christoph Sarrazin; Stefan Zeuzem; Michael P Manns; Markus Cornberg; Eva Herrmann; Heiner Wedemeyer
Journal: PLoS One Date: 2014-04-21 Impact factor: 3.240

6. Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C.

Authors: M Colombo; I Fernández; D Abdurakhmanov; P A Ferreira; S I Strasser; P Urbanek; C Moreno; A Streinu-Cercel; A Verheyen; W Iraqi; R DeMasi; A Hill; J M Läuffer; I Lonjon-Domanec; H Wedemeyer
Journal: Gut Date: 2013-11-07 Impact factor: 23.059

7. Nationwide experience of treatment with protease inhibitors in chronic hepatitis C patients in Denmark: identification of viral resistance mutations.

Authors: Christina Sølund; Henrik Krarup; Santseharay Ramirez; Peter Thielsen; Birgit T Røge; Suzanne Lunding; Toke S Barfod; Lone G Madsen; Britta Tarp; Peer B Christensen; Jan Gerstoft; Alex L Laursen; Jens Bukh; Nina Weis
Journal: PLoS One Date: 2014-12-01 Impact factor: 3.240

Review 8. From hepatitis A to E: A critical review of viral hepatitis.

Authors: Daniel Castaneda; Adalberto Jose Gonzalez; Mohammad Alomari; Kanwarpreet Tandon; Xaralambos Bobby Zervos
Journal: World J Gastroenterol Date: 2021-04-28 Impact factor: 5.742

9. Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting.

Authors: Benjamin Maasoumy; Kerstin Port; Antoaneta Angelova Markova; Beatriz Calle Serrano; Magdalena Rogalska-Taranta; Lisa Sollik; Carola Mix; Janina Kirschner; Michael P Manns; Heiner Wedemeyer; Markus Cornberg
Journal: PLoS One Date: 2013-02-01 Impact factor: 3.240

10. Treatment of naïve patients with chronic hepatitis C genotypes 2 and 3 with pegylated interferon alpha and ribavirin in a real world setting: relevance for the new era of DAA.

Authors: Benjamin Heidrich; Steffen B Wiegand; Peter Buggisch; Holger Hinrichsen; Ralph Link; Bernd Möller; Klaus H W Böker; Gerlinde Teuber; Hartwig Klinker; Elmar Zehnter; Uwe Naumann; Heiner W Busch; Benjamin Maasoumy; Undine Baum; Svenja Hardtke; Michael P Manns; Heiner Wedemeyer; Jörg Petersen; Markus Cornberg
Journal: PLoS One Date: 2014-10-10 Impact factor: 3.240

10 in total